Galmed Pharmaceuticals Ltd.
Develops therapeutics for liver, metabolic, and inflammatory diseases.
GLMD | US
Overview
Corporate Details
- ISIN(s):
- IL0011313900
- LEI:
- Country:
- United States of America
- Address:
- C/O MEITAR LAW OFFICES, 5250608 RAMAT GAN
- Website:
- https://www.galmedpharma.com
- Sector:
- Manufacturing
Description
Galmed Pharmaceuticals Ltd. is a clinical-stage biopharmaceutical company that develops therapeutics for liver, metabolic, and inflammatory diseases. The company's primary focus is on its lead product candidate, Aramchol, an oral therapy for the treatment of metabolic dysfunction-associated steatohepatitis (MASH). Aramchol is being evaluated in late-stage clinical trials, such as the ARMOR Phase 3 study, both as a monotherapy and in combination with other treatments. The company has also announced an expansion of its development activities to include cancer and other major cardiometabolic diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Galmed Pharmaceuticals Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Galmed Pharmaceuticals Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Galmed Pharmaceuticals Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
